Survival of patients with de novo myelodysplastic syndromes (MDS) and del(5q)

被引：0
|
作者：
Gritsaev, S. [1 ]
Martinkevitch, I. [1 ]
Petrova, E. [1 ]
Kostroma, I. [1 ]
Ivanova, M. [1 ]
Sergeev, A. [1 ]
Tiranova, S. [1 ]
Potichonova, N. [1 ]
机构：
[1] Inst Hematol & Transfusiol, St Petersburg, Russia
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70192-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-144
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [31] Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations
    Mallo, Mar
    del Rey, Monica
    Ibanez, Mariam
    Jose Calasanz, Ma
    Arenillas, Leonor
    Jose Larrayoz, Ma
    Pedro, Carmen
    Jerez, Andres
    Maciejewski, Jaroslaw
    Costa, Dolors
    Nomdedeu, Meritxell
    Diez-Campelo, Maria
    Lumbreras, Eva
    Gonzalez-Martinez, Teresa
    Marugan, Isabel
    Such, Esperanza
    Cervera, Jose
    Cigudosa, Juan C.
    Alvarez, Sara
    Florensa, Lourdes
    Hernandez, Jesus Ma
    Sole, Francesc
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (01) : 74 - 86
  • [32] Lenalidomide for myelodysplastic syndromes with del(5q): how long should it last?
    Vozella, Federico
    Latagliata, Roberto
    Carmosino, Ida
    Volpicelli, Paola
    Montagna, Chiara
    Romano, Angela
    Roberto, Amanda
    Finsinger, Paola
    Mancini, Marco
    Breccia, Massimo
    Oliva, Esther
    Alimena, Giuliana
    HEMATOLOGICAL ONCOLOGY, 2015, 33 (01) : 48 - 51
  • [33] Prevalence and Impact on Outcomes of Additional Karyotypic Abnormalities in Patients (Pts) with Myelodysplastic Syndromes (MDS) and Del(5q) from the MDS-003 and MDS-004 Studies
    Giagounidis, Aristoteles
    List, Alan F.
    Hellstroem-Lindberg, Eva
    Mufti, Ghulam J.
    Schlegelberger, Brigitte
    Morrill, John
    Wu, Chengqing
    Skikne, Barry S.
    Fenaux, Pierre
    Goehring, Gudrun
    BLOOD, 2015, 126 (23)
  • [34] IMPACT OF 5Q BREAKPOINTS ON CLINICAL OUTCOMES IN PATIENTS WITH IPSS LOW-/INT-1-RISK MYELODYSPLASTIC SYNDROMES (MDS) AND ISOLATED DEL(5Q) TREATED WITH LENALIDOMIDE IN THE MDS-004 STUDY
    Gohring, G.
    Giagounidis, A.
    List, A.
    Hellstrom-Lindberg, E.
    Sekeres, M.
    Mufti, G.
    Schlegelbergerl, B.
    Morrill, J.
    Wu, C.
    Skikne, B.
    Fenaux, P.
    HAEMATOLOGICA, 2013, 98 : 80 - 80
  • [35] Interphase FISH Does Not Improve the Detection of DEL(5q) and DEL(20q) in Myelodysplastic Syndromes
    Douet-Guilbert, Nathalie
    Herry, Angele
    Le Bris, Marie-Josee
    Gueganic, Nadia
    Bovo, Clement
    Morel, Frederic
    De Braekeleer, Marc
    ANTICANCER RESEARCH, 2011, 31 (03) : 1007 - 1010
  • [36] MYELODYSPLASTIC SYNDROME WITH DEL(5Q) AND LENALIDOMIDE
    Gritsaev, S. V.
    Martinkevitch, I. S.
    Petrova, E. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2013, 58 (02): : 3 - 10
  • [37] Morphological alterations of megakaryocytes in myelodysplastic syndromes with del(5q), del(20q), -7 and del(7q)
    Avino, Daniela
    Di Palma, Anna
    Caliendo, Irene
    Soriente, Ilaria
    Di Feo, Angelo
    Danise, Paolo
    BIOCHIMICA CLINICA, 2016, 40 (03) : 229 - 233
  • [38] Frequency and Prognostic Impact of Complex Chromosomal Aberrations in Patients with Primary Myelodysplastic Syndromes and Del(5q).
    Zemanova, Zuzana
    Michalova, Kyra
    Brezinova, Jana
    Lizcova, Libuse
    Izakova, Silvia
    Bystricka, Dagmar
    Sarova, Iveta
    Berkova, Adela
    Siskova, Magda
    Neuwirtova, Radana
    Cerna, Olga
    Cermak, Jaroslav
    BLOOD, 2009, 114 (22) : 649 - 649
  • [39] Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q).
    Pellagatti, A
    Giagounidis, A
    Killick, S
    Campbell, LJ
    Wraight, V
    Langford, CF
    Fidler, C
    Oscier, D
    Aul, C
    Wainscoat, JS
    Boultwood, J
    BLOOD, 2004, 104 (11) : 649A - 649A
  • [40] Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
    Pellagatti, A
    Cazzola, M
    Giagounidis, A
    Malcovati, L
    Killick, S
    Ramasamy, A
    Oscier, D
    Aul, C
    Wainscoat, JS
    Boultwood, J
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 60 - 60
12345